Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8891)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2017 (publication date) through Jan 1, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Noguchi R, Kaji K, Namisaki T, Moriya K, Kitade M, Takeda K, Kawaratani H, Okura Y, Aihara Y, Furukawa M, Mitoro A, Yoshiji H. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B. World J Gastroenterol 2017; 23(36): 6705-6714 [PMID: 29085215 DOI: 10.3748/wjg.v23.i36.6705] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i36/6705.htm |
| Number | Citing Articles |
| 1 |
Keyur Patel, Sumeet K. Asrani, Maria Isabel Fiel, Deborah Levine, Daniel H. Leung, Andres Duarte-Rojo, Jonathan A. Dranoff, Tarek Nayfeh, Bashar Hasan, Tamar H. Taddei, Yahya Alsawaf, Samer Saadi, Abdul Mounaem Majzoub, Apostolos Manolopoulos, Muayad Alzuabi, Jingyi Ding, Nigar Sofiyeva, Mohammad H. Murad, Mouaz Alsawas, Don C. Rockey, Richard K. Sterling. Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology 2025; 81(1): 358 doi: 10.1097/HEP.0000000000000842
|
| 2 |
Tao Zhang, Xiao-Feng Wang, Zheng-Cai Wang, Dong Lou, Qing-Qing Fang, Yan-Yan Hu, Wan-Yi Zhao, Li-Yun Zhang, Li-Hong Wu, Wei-Qiang Tan. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation. Biomedicine & Pharmacotherapy 2020; 129: 110287 doi: 10.1016/j.biopha.2020.110287
|
| 3 |
Shu Feng, Zhonghao Wang, Yanhua Zhao, Chuanmin Tao. Wisteria floribunda agglutinin-positive Mac-2-binding protein as a diagnostic biomarker in liver cirrhosis: an updated meta-analysis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-67471-y
|
| 4 |
Ming Jian Lian, Zhi Qi Chen, Qian Ming Wang, Gang Sen Zheng, Guo Lin Hong. Diagnostic accuracy of mac‐2‐binding protein glycosylation isomer for diagnosing hepatitis B‐related fibrosis: A meta‐analysis. Journal of Digestive Diseases 2022; 23(10): 550 doi: 10.1111/1751-2980.13140
|
| 5 |
Siyao Gong, Xin Yu, Qian Li, Ming Chen, Shuguang Yu, Sha Yang. Evaluation of Mac-2 binding protein glycosylation isomer (M2BPGi) as a diagnostic marker for staging liver fibrosis: a meta-analysis. PeerJ 2024; 12: e17611 doi: 10.7717/peerj.17611
|
| 6 |
Ana Luisa Cardoso, Adelaide Fernandes, Juan Antonio Aguilar-Pimentel, Martin Hrabě de Angelis, Joana Ribeiro Guedes, Maria Alexandra Brito, Saida Ortolano, Giovambattista Pani, Sophia Athanasopoulou, Efstathios S. Gonos, Markus Schosserer, Johannes Grillari, Pärt Peterson, Bilge Guvenc Tuna, Soner Dogan, Angelika Meyer, Ronald van Os, Anne-Ulrike Trendelenburg. Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases. Ageing Research Reviews 2018; 47: 214 doi: 10.1016/j.arr.2018.07.004
|
| 7 |
Aline Silva Miranda, Ana Cristina Simões e Silva. Serum levels of angiotensin converting enzyme as a biomarker of liver fibrosis. World Journal of Gastroenterology 2017; 23(48): 8439-8442 doi: 10.3748/wjg.v23.i48.8439
|
| 8 |
Sameh Saber. Angiotensin II: a key mediator in the development of liver fibrosis and cancer. Bulletin of the National Research Centre 2018; 42(1) doi: 10.1186/s42269-018-0020-7
|
| 9 |
Jeanne Perpétue Vincent, Gibril Ndow, Shintaro Ogawa, Amie Ceesay, Ramou Njie, Bakary Sanneh, Ignatius Baldeh, Umberto D’Alessandro, Maimuna Mendy, Mark Thursz, Isabelle Chemin, Yasuhito Tanaka, Maud Lemoine, Yusuke Shimakawa. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa. Journal of Global Health 2022; 12 doi: 10.7189/jogh.12.04076
|
| 10 |
Ludwig J. Horst, Sören Weidemann, Ansgar W. Lohse, Marcial Sebode. Hepatische Granulome – eine diagnostische Herausforderung. Zeitschrift für Rheumatologie 2022; 81(7): 567 doi: 10.1007/s00393-022-01235-z
|
| 11 |
Enas Abdul Kareem, Amer Abdullah Sachit, Qasim Ali Khazal. The role of the renin–angiotensin system in the pathogenesis of COVID-19. 1ST SAMARRA INTERNATIONAL CONFERENCE FOR PURE AND APPLIED SCIENCES (SICPS2021): SICPS2021 2022; 2394: 020023 doi: 10.1063/5.0121763
|
| 12 |
Xinyu Liu, Wei Zhang, Baofeng Ma, Chunlei Lv, Mimi Sun, Qinghua Shang. The value of serum Mac-2 binding protein glycosylation isomer in the diagnosis of liver fibrosis: a systematic review and meta-analysis. Frontiers in Physiology 2024; 15 doi: 10.3389/fphys.2024.1382293
|
| 13 |
Yu‐Hsin Tseng, Rei‐Cheng Yang, Tzong‐Shi Lu. Two hits to the renin‐angiotensin system may play a key role in severe COVID‐19. The Kaohsiung Journal of Medical Sciences 2020; 36(6): 389 doi: 10.1002/kjm2.12237
|
| 14 |
Mauno Vihinen. Functional effects of protein variants. Biochimie 2021; 180: 104 doi: 10.1016/j.biochi.2020.10.009
|
| 15 |
Xue-Ying Xu, Wu-Sheng Wang, Qi-Meng Zhang, Jun-Ling Li, Jin-Bin Sun, Tian-Tian Qin, Hong-Bo Liu. Performance of common imaging techniques <i>vs</i> serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis. World Journal of Clinical Cases 2019; 7(15): 2022-2037 doi: 10.12998/wjcc.v7.i15.2022
|
| 16 |
Keiji Yokoyama, Hiromi Fukuda, Ryo Yamauchi, Masashi Higashi, Takashi Miyayama, Tomotaka Higashi, Yotaro Uchida, Kumiko Shibata, Naoaki Tsuchiya, Atsushi Fukunaga, Kaoru Umeda, Kazuhide Takata, Takashi Tanaka, Satoshi Shakado, Shotaro Sakisaka, Fumihito Hirai. Long-Term Effects of Rifaximin on Patients with Hepatic Encephalopathy: Its Possible Effects on the Improvement in the Blood Ammonia Concentration Levels, Hepatic Spare Ability and Refractory Ascites. Medicina 2022; 58(9): 1276 doi: 10.3390/medicina58091276
|